Sponsors EAP

Sponsors EAP

Expanded Access Programs offer a variety of benefits to the sponsoring pharmaceutical company.

  • These regulatory approved programs provide companies with additional opportunities to assess a drug prior to the full launch
  • Companies can generate additional safety and real world data that helps in understanding how the drug will be used in clinical practice
  • Sponsors can manage risk in the pre-launch setting through appropriate adverse event capture and screening patients to ensure the correct cohorts are selected to take the medicine
  • The programs give physicians experience with using the new medicine, creating advocates for the drug prior to its launch
  • EAPs help a company build relationships with both doctors and patients

If you are a Sponsor and have a product that is in development and you require the deployment of a EAP or distribution of your drugs to manage product requests from patients/physicians, please contact us.

For more information contact:
eap@wepclinical.com
+1 919 694 5088
+44 208 004 8186